South Korea approves its 1st AI medical imaging device

South Korea is the latest nation to incorporate artificial intelligence (AI) in their healthcare system. Today, South Korea's Ministry of Food and Drug and Safety approved its first AI-based medical device, according to an article published May 16 by the Korea Herald.  

The newly approved image diagnostics device, called the VUNOmed-BoneAge, uses deep learning to interpret x-ray of a patients left hand to determine their skeletal age, according to the article. The AI technology startup Vuno and the Asan Medical Center, both based in Seoul, developed the device.  

"Vuno’s AI-powered device identifies a person’s skeletal age by comparing the inputted x-ray slide with a similar bone image pre-identified as being of a certain age and gives an instant diagnosis," according to the article.  

Vuno told the Korea Herald that the device can raise diagnostic accuracy by 8 percent and cut diagnostic wait time by 40 percent. Ultimately, the device is designed for use in pediatrics to predict a child's growth and guide treatment for growth disorders.  

Read more at the link below:

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup